Index by author

01 January 2012; volume 39, issue 1

A

  1. Akindipe, O.A.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  2. Alfageme, I.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  3. Almendros, I.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

  4. Almstrand, A-C.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

  5. Anderson, J.A.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  6. Antony, V.B.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  7. Arakaki, D.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  8. Arnulf, I.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  9. Aspa, J.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  10. Attali, V.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  11. Azzari, S.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

B

  1. Barba, R.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  2. Bast, A.

    1. Drent, M. et al "Cat litter is a possible trigger for sarcoidosis." European Respiratory Journal 39.1 (2012): 221-222. Web. 26 Sept2023.

  3. Bateman, E.D.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.

  4. Baz, M.A.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  5. Beardsmore, C.S.

    1. Strippoli, M-P.F. et al "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 229. Web. 26 Sept2023.

  6. Belchenko, D.D.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

  7. Bello, S.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  8. Berghmans, T.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  9. Blake, K.

    1. Blake, K. et al "Bioavailability of inhaled fluticasone propionate via chambers/masks in young children." European Respiratory Journal 39.1 (2012): 97-103. Web. 26 Sept2023.

  10. Blasco, L.M.

    1. Blasco, L.M.. "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 224-225. Web. 26 Sept2023.

  11. Bonduelle, Y.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  12. Boots, A.W.

    1. Drent, M. et al "Cat litter is a possible trigger for sarcoidosis." European Respiratory Journal 39.1 (2012): 221-222. Web. 26 Sept2023.

  13. Borderías, L.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  14. Borget, I.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  15. Boulle, A.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  16. Boutron-Ruault, M.C.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  17. Brand, P.L.P.

    1. Carroll, W.D., J. Wildhaber, and P.L.P. Brand. "Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey." European Respiratory Journal 39.1 (2012): 90-96. Web. 26 Sept2023.

  18. Bredberg, A.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

  19. Bredenbröker, D.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.

  20. Breithecker, A.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  21. Brion, A.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  22. Brose, M.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.

  23. Brown, K.K.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

C

  1. Cadranel, J.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.
    2. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  2. Calverley, P.M.A.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.
    2. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  3. Canora, J.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  4. Capelastegui, A.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  5. Carroll, W.D.

    1. Carroll, W.D., J. Wildhaber, and P.L.P. Brand. "Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey." European Respiratory Journal 39.1 (2012): 90-96. Web. 26 Sept2023.

  6. Casaburi, R.

    1. Palange, P., R. Casaburi, and S.A. Ward. "Prof. Brian James Whipp, 1937–2011: a master in respiratory and exercise physiology." European Respiratory Journal 39.1 (2012): 1-2. Web. 26 Sept2023.

  7. Caspani, L.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

  8. Castiglioni, P.

    1. Castiglioni, P. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 226-227. Web. 26 Sept2023.

  9. Celli, B.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  10. Chalmers, J.D.

    1. Singanayagam, A. et al "Is community-acquired pneumonia an independent risk factor for cardiovascular disease?." European Respiratory Journal 39.1 (2012): 187-196. Web. 26 Sept2023.

  11. Checa, M.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  12. Chouaid, C.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  13. Churg, A.

    1. Churg, A., S. Zhou, and J.L. Wright. "Matrix metalloproteinases in COPD." European Respiratory Journal 39.1 (2012): 197-209. Web. 26 Sept2023.

  14. Cisneros, J.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  15. Clavel-Chapelon, F.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  16. Cohen-Kaminsky, S.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  17. Colvin, K.L.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

  18. Comignani, P.D.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  19. Constantopoulos, S.H.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  20. Cortelli, P.

    1. Castiglioni, P. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 226-227. Web. 26 Sept2023.

  21. Coudert, B.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  22. Crotti, S.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

  23. Cs Toth, I.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

D

  1. Dalavanga, Y.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  2. Daniel, C.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  3. Dansin, E.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  4. Daskalopoulos, G.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  5. de Castro, F.R.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  6. de Jongste, J.C.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  7. Drent, M.

    1. Drent, M. et al "Cat litter is a possible trigger for sarcoidosis." European Respiratory Journal 39.1 (2012): 221-222. Web. 26 Sept2023.

  8. Due, K.M.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

  9. Duijts, L.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  10. Duran-Cantolla, J.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

E

  1. Elder, D.H.J.

    1. Singanayagam, A. et al "Is community-acquired pneumonia an independent risk factor for cardiovascular disease?." European Respiratory Journal 39.1 (2012): 187-196. Web. 26 Sept2023.

  2. Englisch, C.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  3. Ewert, R.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

F

  1. Fabbri, L.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.

  2. Farré, R.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

  3. Faruqi, I.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  4. Felix, S.B.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  5. Ferguson, G.T.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  6. Fernandez-Bussy, S.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  7. Fernandez-Perez, E.R.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

  8. Fielding, K.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  9. Fischer, A.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

  10. Fonseca, G.H.H.

    1. Fonseca, G.H.H. et al "Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease." European Respiratory Journal 39.1 (2012): 112-118. Web. 26 Sept2023.

  11. Friard, S.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  12. Frija-Orvoen, E.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  13. Fuselli, J.J.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

G

  1. Gambarte, J.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  2. Gambaryan, N.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  3. Garcia, C.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  4. García-de-Alba, C.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  5. Gattinoni, L.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

  6. Ghofrani, H-A.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  7. Gideon, H.P.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  8. Gimeno, G.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  9. Giner, V.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  10. Girerd, B.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  11. Gläser, S.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  12. Glynn, J.R.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  13. Goehring, U.M.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.

  14. Gogali, A.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  15. Goliath, R.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  16. Gualandro, S.F.M.

    1. Fonseca, G.H.H. et al "Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease." European Respiratory Journal 39.1 (2012): 112-118. Web. 26 Sept2023.

H

  1. Helminen, M.

    1. Koponen, P. et al "Preschool asthma after bronchiolitis in infancy." European Respiratory Journal 39.1 (2012): 76-80. Web. 26 Sept2023.

  2. Hendeles, L.

    1. Blake, K. et al "Bioavailability of inhaled fluticasone propionate via chambers/masks in young children." European Respiratory Journal 39.1 (2012): 97-103. Web. 26 Sept2023.

  3. Hensel, E.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  4. Hofman, A.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  5. Holbrechts, S.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  6. Howard, L.S.

    1. O'Driscoll, B.R. et al "An audit of hypoxaemia, hyperoxaemia, hypercapnia and acidosis in blood gas specimens." European Respiratory Journal 39.1 (2012): 219-221. Web. 26 Sept2023.

  7. Huertas, A.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  8. Huie, T.J.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

  9. Humbert, M.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

I

  1. Ittermann, T.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  2. Ivy, D.D.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

J

  1. Jaddoe, V.W.V.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  2. Jardim, C.V.P.

    1. Fonseca, G.H.H. et al "Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease." European Respiratory Journal 39.1 (2012): 112-118. Web. 26 Sept2023.

  3. Jenkins, C.R.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  4. Jones, P.W.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  5. Josefson, M.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

K

  1. Kauffmann, F.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  2. Kleinert, M.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  3. Koch, B.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  4. Konofal, E.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  5. Konstantinidis, A.K.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  6. Koponen, P.

    1. Koponen, P. et al "Preschool asthma after bronchiolitis in infancy." European Respiratory Journal 39.1 (2012): 76-80. Web. 26 Sept2023.

  7. Kornum, J.B.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

  8. Korppi, M.

    1. Korppi, M.. "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 228-229. Web. 26 Sept2023.
    2. Koponen, P. et al "Preschool asthma after bronchiolitis in infancy." European Respiratory Journal 39.1 (2012): 76-80. Web. 26 Sept2023.

  9. Koubaniou, C.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  10. Kovacs, G.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  11. Kuehni, C.E.

    1. Strippoli, M-P.F. et al "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 229. Web. 26 Sept2023.

  12. Kunka, R.L.

    1. Blake, K. et al "Bioavailability of inhaled fluticasone propionate via chambers/masks in young children." European Respiratory Journal 39.1 (2012): 97-103. Web. 26 Sept2023.

L

  1. Laffaye, N.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  2. Lafitte, J.J.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  3. Larsson, P.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

  4. Lausmaa, J.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

  5. Lecomte, J.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  6. Le Moual, N.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  7. Lissoni, A.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

  8. Lombardi, C.

    1. Castiglioni, P. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 226-227. Web. 26 Sept2023.

  9. Lopez, D.

    1. Waterer, G.W., and D. Lopez. "Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect." European Respiratory Journal 39.1 (2012): 7-8. Web. 26 Sept2023.

  10. Losa, J.E.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  11. Louviaux, I.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  12. Luukkaala, T.

    1. Koponen, P. et al "Preschool asthma after bronchiolitis in infancy." European Respiratory Journal 39.1 (2012): 76-80. Web. 26 Sept2023.

M

  1. Maartens, G.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  2. Macchia, A.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  3. Madelaine, J.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  4. Madroszyk, A.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  5. Maldonado, V.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  6. Manda-Stachouli, C.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  7. Marco, J.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  8. Markiewicz, E.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  9. Martín-Villasclaras, J.J.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  10. Massolin, H.P.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  11. Mathee, S.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  12. Mathieu, N.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  13. Matthaiou, M.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  14. Meert, A.P.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  15. Mehta, R.

    1. Blake, K. et al "Bioavailability of inhaled fluticasone propionate via chambers/masks in young children." European Respiratory Journal 39.1 (2012): 97-103. Web. 26 Sept2023.

  16. Melendez-Zajgla, J.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  17. Menéndez, R.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  18. Mohammed, K.A.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  19. Molinos, L.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  20. Moll, H.A.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  21. Montani, D.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  22. Montaño, M.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  23. Montes, E.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  24. Montes-Worboys, A.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  25. Montserrat, J.M.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

  26. Morin, F.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  27. Morrell, N.W.

    1. Toshner, M.R., and N.W. Morrell. "The fibrocyte in pulmonary hypertension: we seek him here, we seek him there." European Respiratory Journal 39.1 (2012): 5-6. Web. 26 Sept2023.

  28. Mubarak, K.K.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  29. Mwansa-Kambafwile, J.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

N

  1. Nasreen, N.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  2. Nathan, S.D.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  3. Nauck, M.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  4. Navajas, D.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

  5. Nguyen, C.M.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

  6. Nørgaard, M.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

  7. Ntzani, E.E.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

O

  1. O'Driscoll, B.R.

    1. O'Driscoll, B.R. et al "An audit of hypoxaemia, hyperoxaemia, hypercapnia and acidosis in blood gas specimens." European Respiratory Journal 39.1 (2012): 219-221. Web. 26 Sept2023.

  2. Olin, A-C.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

  3. Olschewski, H.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  4. Olson, A.L.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

  5. Ordoñez-Razo, R.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  6. Oryszczyn, M.P.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  7. Overvad, K.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

P

  1. Paassilta, M.

    1. Koponen, P. et al "Preschool asthma after bronchiolitis in infancy." European Respiratory Journal 39.1 (2012): 76-80. Web. 26 Sept2023.

  2. Paesmans, M.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  3. Pai, M.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  4. Palange, P.

    1. Palange, P., R. Casaburi, and S.A. Ward. "Prof. Brian James Whipp, 1937–2011: a master in respiratory and exercise physiology." European Respiratory Journal 39.1 (2012): 1-2. Web. 26 Sept2023.

  5. Parati, G.

    1. Castiglioni, P. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 226-227. Web. 26 Sept2023.

  6. Pardo, A.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  7. Parent, F.

    1. Simonneau, G., and F. Parent. "Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different." European Respiratory Journal 39.1 (2012): 3-4. Web. 26 Sept2023.

  8. Pasleau, F.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  9. Perros, F.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  10. Pescatore, A.M.

    1. Strippoli, M-P.F. et al "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 229. Web. 26 Sept2023.

  11. Pignon, J-P.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

  12. Plaza, S.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  13. Pottier, M.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

Q

  1. Quoix, E.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.

R

  1. Rabe, K.F.

    1. Bateman, E.D. et al "Avoiding backward steps in COPD: looking again at roflumilast." European Respiratory Journal 39.1 (2012): 225-226. Web. 26 Sept2023.

  2. Ramírez, J.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

  3. Rangaka, M.X.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  4. Redolfi, S.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  5. Regev, D.

    1. Mubarak, K.K. et al "Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 133-140. Web. 26 Sept2023.

  6. Reichenberger, F.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  7. Rello, J.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  8. Reyes, S.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  9. Richez, M.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  10. Rodriguez Moncalvo, J.J.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  11. Roelandts, M.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  12. Romero, M.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  13. Romieu, I.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  14. Rosado, C.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  15. Rudenski, A.

    1. O'Driscoll, B.R. et al "An audit of hypoxaemia, hyperoxaemia, hypercapnia and acidosis in blood gas specimens." European Respiratory Journal 39.1 (2012): 219-221. Web. 26 Sept2023.

  16. Ruiz, V.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  17. Ruiz-Manzano, J.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  18. Ryu, J.H.

    1. Ryu, J.H., H. Sekiguchi, and E.S. Yi. "Pulmonary manifestations of immunoglobulin G4-related sclerosing disease." European Respiratory Journal 39.1 (2012): 180-186. Web. 26 Sept2023.

S

  1. Salemi, V.M.C.

    1. Fonseca, G.H.H. et al "Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease." European Respiratory Journal 39.1 (2012): 112-118. Web. 26 Sept2023.

  2. Schäper, C.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  3. Scheidl, S.J.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  4. Schermer, T.R.J.

    1. van Dijk, W.D., T.R.J. Schermer, and C. van Weel. "Prognostic indices for COPD patient management: how many do we need?." European Respiratory Journal 39.1 (2012): 223-224. Web. 26 Sept2023.

  5. Scherpereel, A.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  6. Schulz, H.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  7. Schulz, R.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  8. Sculier, J.P.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  9. Seeger, W.

    1. Scheidl, S.J. et al "Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients." European Respiratory Journal 39.1 (2012): 119-124. Web. 26 Sept2023.

  10. Seferian, A.

    1. Gambaryan, N. et al "Circulating fibrocytes and pulmonary arterial hypertension." European Respiratory Journal 39.1 (2012): 210-212. Web. 26 Sept2023.

  11. Sekiguchi, H.

    1. Ryu, J.H., H. Sekiguchi, and E.S. Yi. "Pulmonary manifestations of immunoglobulin G4-related sclerosing disease." European Respiratory Journal 39.1 (2012): 180-186. Web. 26 Sept2023.

  12. Selman, M.

    1. Montes, E. et al "Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis." European Respiratory Journal 39.1 (2012): 141-148. Web. 26 Sept2023.

  13. Silverman, M.

    1. Strippoli, M-P.F. et al "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 229. Web. 26 Sept2023.

  14. Similowski, T.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  15. Simonneau, G.

    1. Simonneau, G., and F. Parent. "Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different." European Respiratory Journal 39.1 (2012): 3-4. Web. 26 Sept2023.

  16. Singanayagam, A.

    1. Singanayagam, A. et al "Is community-acquired pneumonia an independent risk factor for cardiovascular disease?." European Respiratory Journal 39.1 (2012): 187-196. Web. 26 Sept2023.
    2. Singanayagam, A. et al "Is community-acquired pneumonia an independent risk factor for cardiovascular disease?." European Respiratory Journal 39.1 (2012): 187-196. Web. 26 Sept2023.

  17. Sjövall, P.

    1. Almstrand, A-C. et al "TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls." European Respiratory Journal 39.1 (2012): 59-66. Web. 26 Sept2023.

  18. Solomon, J.J.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

  19. Sonnenschein-van der Voort, A.M.M.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  20. Sørensen, H.T.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

  21. Souza, R.

    1. Fonseca, G.H.H. et al "Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease." European Respiratory Journal 39.1 (2012): 112-118. Web. 26 Sept2023.

  22. Spencer, T.

    1. Blake, K. et al "Bioavailability of inhaled fluticasone propionate via chambers/masks in young children." European Respiratory Journal 39.1 (2012): 97-103. Web. 26 Sept2023.

  23. Sprunger, D.B.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

  24. Spycher, B.D.

    1. Strippoli, M-P.F. et al "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 229. Web. 26 Sept2023.

  25. Stefanou, D.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  26. Stenmark, K.R.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

  27. Strippoli, M-P.F.

    1. Strippoli, M-P.F. et al "Viral wheezing is virus specific and not just host specific." European Respiratory Journal 39.1 (2012): 229. Web. 26 Sept2023.

  28. Swigris, J.J.

    1. Sprunger, D.B. et al "Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease." European Respiratory Journal 39.1 (2012): 125-132. Web. 26 Sept2023.

T

  1. Takatsuki, S.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

  2. Tarsia, P.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

  3. Thomsen, R.W.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

  4. Titus, R.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  5. Tjønneland, A.

    1. Kornum, J.B. et al "Alcohol drinking and risk of subsequent hospitalisation with pneumonia." European Respiratory Journal 39.1 (2012): 149-155. Web. 26 Sept2023.

  6. Tognoni, G.

    1. Macchia, A. et al "Unrecognised ventricular dysfunction in COPD." European Respiratory Journal 39.1 (2012): 51-58. Web. 26 Sept2023.

  7. Torres, A.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  8. Torres, M.

    1. Almendros, I. et al "Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea." European Respiratory Journal 39.1 (2012): 215-217. Web. 26 Sept2023.

  9. Toshner, M.R.

    1. Toshner, M.R., and N.W. Morrell. "The fibrocyte in pulmonary hypertension: we seek him here, we seek him there." European Respiratory Journal 39.1 (2012): 5-6. Web. 26 Sept2023.

  10. Tubiolo, D.

    1. Crotti, S. et al "Artificial lung as an alternative to mechanical ventilation in COPD exacerbation." European Respiratory Journal 39.1 (2012): 212-215. Web. 26 Sept2023.

  11. Tulippe, Ch.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  12. Turkington, P.M.

    1. O'Driscoll, B.R. et al "An audit of hypoxaemia, hyperoxaemia, hypercapnia and acidosis in blood gas specimens." European Respiratory Journal 39.1 (2012): 219-221. Web. 26 Sept2023.

V

  1. van der Valk, R.J.P.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  2. van Dijk, W.D.

    1. van Dijk, W.D., T.R.J. Schermer, and C. van Weel. "Prognostic indices for COPD patient management: how many do we need?." European Respiratory Journal 39.1 (2012): 223-224. Web. 26 Sept2023.

  3. Van Houtte, P.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  4. Van Schil, P.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  5. van Weel, C.

    1. van Dijk, W.D., T.R.J. Schermer, and C. van Weel. "Prognostic indices for COPD patient management: how many do we need?." European Respiratory Journal 39.1 (2012): 223-224. Web. 26 Sept2023.

  6. Varraso, R.

    1. Varraso, R. et al "Farming in childhood, diet in adulthood and asthma history." European Respiratory Journal 39.1 (2012): 67-75. Web. 26 Sept2023.

  7. Vernet, C.

    1. Vernet, C. et al "Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment." European Respiratory Journal 39.1 (2012): 227-228. Web. 26 Sept2023.

  8. Vestbo, J.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  9. Vogelmeier, C.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  10. Völzke, H.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

W

  1. Wachters, C.

    1. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  2. Wallaschofski, H.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  3. Ward, S.A.

    1. Palange, P., R. Casaburi, and S.A. Ward. "Prof. Brian James Whipp, 1937–2011: a master in respiratory and exercise physiology." European Respiratory Journal 39.1 (2012): 1-2. Web. 26 Sept2023.

  4. Warnke, C.

    1. Gläser, S. et al "Airflow limitation, lung volumes and systemic inflammation in a general population." European Respiratory Journal 39.1 (2012): 29-37. Web. 26 Sept2023.

  5. Waterer, G.W.

    1. Waterer, G.W., and D. Lopez. "Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect." European Respiratory Journal 39.1 (2012): 7-8. Web. 26 Sept2023.

  6. Westeel, V.

    1. Borget, I. et al "Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3." European Respiratory Journal 39.1 (2012): 172-179. Web. 26 Sept2023.
    2. Berghmans, T. et al "Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations." European Respiratory Journal 39.1 (2012): 9-28. Web. 26 Sept2023.

  7. Wijnen, P.A.

    1. Drent, M. et al "Cat litter is a possible trigger for sarcoidosis." European Respiratory Journal 39.1 (2012): 221-222. Web. 26 Sept2023.

  8. Wildhaber, J.

    1. Carroll, W.D., J. Wildhaber, and P.L.P. Brand. "Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey." European Respiratory Journal 39.1 (2012): 90-96. Web. 26 Sept2023.

  9. Wilkinson, K.A.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  10. Wilkinson, R.J.

    1. Rangaka, M.X. et al "Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms." European Respiratory Journal 39.1 (2012): 163-171. Web. 26 Sept2023.

  11. Willemsen, S.P.

    1. Sonnenschein-van der Voort, A.M.M. et al "Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms." European Respiratory Journal 39.1 (2012): 81-89. Web. 26 Sept2023.

  12. Wright, J.L.

    1. Churg, A., S. Zhou, and J.L. Wright. "Matrix metalloproteinases in COPD." European Respiratory Journal 39.1 (2012): 197-209. Web. 26 Sept2023.

Y

  1. Yates, J.C.

    1. Jenkins, C.R. et al "Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study." European Respiratory Journal 39.1 (2012): 38-45. Web. 26 Sept2023.

  2. Yeager, M.E.

    1. Yeager, M.E. et al "Circulating fibrocytes are increased in children and young adults with pulmonary hypertension." European Respiratory Journal 39.1 (2012): 104-111. Web. 26 Sept2023.

  3. Yi, E.S.

    1. Ryu, J.H., H. Sekiguchi, and E.S. Yi. "Pulmonary manifestations of immunoglobulin G4-related sclerosing disease." European Respiratory Journal 39.1 (2012): 180-186. Web. 26 Sept2023.

Z

  1. Zalacain, R.

    1. Menéndez, R. et al "Initial management of pneumonia and sepsis: factors associated with improved outcome." European Respiratory Journal 39.1 (2012): 156-162. Web. 26 Sept2023.

  2. Zampira, I.

    1. Gogali, A. et al "Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later." European Respiratory Journal 39.1 (2012): 217-219. Web. 26 Sept2023.

  3. Zapatero, A.

    1. Barba, R. et al "The impact of weekends on outcome for acute exacerbations of COPD." European Respiratory Journal 39.1 (2012): 46-50. Web. 26 Sept2023.

  4. Zhou, S.

    1. Churg, A., S. Zhou, and J.L. Wright. "Matrix metalloproteinases in COPD." European Respiratory Journal 39.1 (2012): 197-209. Web. 26 Sept2023.
Back to top
European Respiratory Journal: 39 (1)

Search Within This Issue

Jump to

Manage Table of content Alerts